Weekly subcutaneous injection with stepwise increases (e.g., 2.5 mg up to 15 mg as tolerated per label)
As of the most recent update on September 27th, 2024, enclomiphene citrate is category 1 on the Bulk Drug Substances Nominated for Use in Compounding Under Section 503A of the Federal Food, Drug, and Cosmetic Act
In the STEP 8 trial, more people stopped liraglutide due to side effects (12.6%) than semaglutide (3.2%)
Charging efficiency analysis Charging efficiency is an important indicator for measuring the charging performance of lithium batteries
The benefits of lipotropic injections aren't limited to weight loss
Peer review Peer review information Nature Reviews Rheumatology thanks Tak-Mao Chan, Mariele Gatto and the other, anonymous, reviewers for their contribution to the peer review of this work